Centre de documentació: resultats de cerca | Siidon | Guttmann

Cercador

Origin of Impairment and Timing of Impairment Manifestation in Paralympic Sport.
Autor/s:
Neto FR, Winckler C, Costa RRG.
Letters to the Editor
Any publicació:
2024
Número de revista:
American Journal of Physical Medicine & Rehabilitation vol. 103 n. 8
https://journals.lww.com/ajpmr/fulltext/2024/08000/evidence_based_physiatry__dia…
Response to Neto et al. "Origin of Impairment and Timing of Impairment Manifestation in Paralympic Sport".
Autor/s:
Kons RL, Patatas JM.
Letters to the Editor
Any publicació:
2024
Número de revista:
American Journal of Physical Medicine & Rehabilitation vol. 103 n. 8
https://journals.lww.com/ajpmr/fulltext/2024/08000/evidence_based_physiatry__dia…
Athlete Impairments in Paralympic Sports.
Autor/s:
van den Hoek D, Beaumont P, Latella C.
Letters to the Editor
Any publicació:
2024
Número de revista:
American Journal of Physical Medicine & Rehabilitation vol. 103 n. 8
https://journals.lww.com/ajpmr/fulltext/2024/08000/evidence_based_physiatry__dia…
Distinguishing Between Myelin Oligodendrocyte Glycoprotein Disease Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy.
Autor/s:
Park GT, Galetta S.
Editorial
Any publicació:
2024
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 11 n. 3
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200240
Post-COVID Small Fiber Neuropathy, Implications of Innate Immunity, and Challenges on IVIG Therapy.
Autor/s:
Dalakas MC.
Editorial
Any publicació:
2024
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 11 n. 3
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200240
Proteomics Analysis Moves the Needle by Generating Clinical Diagnostic Markers.
Autor/s:
Teunissen CE.
Editorial
Any publicació:
2024
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 11 n. 3
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200240
Article
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial.
Autor/s:
Fox RJ, Wiendl H, Wolf C, De Stefano N, Sellner J, Gryb V, Rejdak K, Bozhinov PS, Vitt D, Kohlhof H, Slizgi J, Ondrus M, Sciacca V, Muehler AR; EMPhASIS investigators.
Any publicació:
2024
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 11 n. 3
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200240
Article
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections.
Autor/s:
Langer-Gould A, Li BH, Smith JB, Xu S.
Any publicació:
2024
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 11 n. 3
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200240
Article
ingle-Cell Multi-Omics Map of Cell Type-Specific Mechanistic Drivers of Multiple Sclerosis Lesions.
Autor/s:
Elkjaer ML, Hartebrodt A, Oubounyt M, Weber A, Vitved L, Reynolds R, Thomassen M, Rottger R, Baumbach J, Illes Z.
Any publicació:
2024
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 11 n. 3
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200240
Article
Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy.
Autor/s:
Tisavipat N, Stiebel-Kalish H, Palevski D, Bialer OY, Moss HE, Chaitanuwong P, Padungkiatsagul T, Henderson AD, Sotirchos ES, Singh S, Salman AR, Tajfirouz DA, Chodnicki KD, Pittock SJ, Flanagan EP, Chen JJ. ...
Any publicació:
2024
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 11 n. 3
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200240